Literature DB >> 15895524

15-amido erythromycins: synthesis and in vitro activity of a new class of macrolide antibiotics.

Simon J Shaw1, Darren Abbanat, Gary W Ashley, Karen Bush, Barbara Foleno, Mark Macielag, Dan Zhang, David C Myles.   

Abstract

An array of 15-amido substituted erythromycin A compounds was synthesized using a chemobiosynthesis approach. It was found that while the in vitro antibacterial activities of aryl amides were inferior to erythromycin A, substituted benzylamides showed equivalent and in some cases improved activity against the macrolide-resistant strains. The 15-amidoerythromycins represent a new class of antibacterial macrolides.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15895524     DOI: 10.1038/ja.2005.19

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  5 in total

Review 1.  The macrolide antibiotic renaissance.

Authors:  George P Dinos
Journal:  Br J Pharmacol       Date:  2017-08-10       Impact factor: 8.739

2.  Precursor directed biosynthesis of an orthogonally functional erythromycin analogue: selectivity in the ribosome macrolide binding pocket.

Authors:  Colin J B Harvey; Joseph D Puglisi; Vijay S Pande; David E Cane; Chaitan Khosla
Journal:  J Am Chem Soc       Date:  2012-07-11       Impact factor: 15.419

3.  Synthesis and antibacterial activity of a novel class of 15-membered macrolide antibiotics, "11a-azalides".

Authors:  Tomohiro Sugimoto; Tetsuya Tanikawa
Journal:  ACS Med Chem Lett       Date:  2010-12-30       Impact factor: 4.345

4.  Bioassay-guided evolution of glycosylated macrolide antibiotics in Escherichia coli.

Authors:  Ho Young Lee; Chaitan Khosla
Journal:  PLoS Biol       Date:  2007-02       Impact factor: 8.029

5.  Antibacterial activity of 2-(2',4'-dibromophenoxy)-4,6-dibromophenol from Dysidea granulosa.

Authors:  Divya M P Shridhar; Girish B Mahajan; Vijayendra P Kamat; Chandrakant G Naik; Rajashri R Parab; Nidhi R Thakur; Prabhu D Mishra
Journal:  Mar Drugs       Date:  2009-09-22       Impact factor: 5.118

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.